Among the 13 apolipoproteins studied in PROCARDIS, the associations of triglyceride-related apolipoproteins ApoC1, ApoC3, and ApoE were strongly and positively associated with risk of CHD after adjustment for triglycerides and other conventional lipid measures and correction for statin treatment. Here, APOC3 is linked to coronary artery disorder.